Home » Business » Wall Street Falls as Tech Earnings Disappoint & Inflation Data Looms

Wall Street Falls as Tech Earnings Disappoint & Inflation Data Looms

by Victoria Sterling -Business Editor

U.S. Equities retreated sharply on Thursday, , as a renewed selloff in technology stocks weighed on the market, adding to concerns stemming from recent economic data. The Nasdaq Composite, S&P 500, and Dow Jones Industrial Average all experienced significant declines, with the Dow shedding roughly 500 points during the session.

The downturn followed a period of consecutive record highs, particularly in blue-chip stocks, highlighting a swift shift in investor sentiment away from growth-heavy names. Cisco Systems Inc. Triggered much of the initial weakness, plummeting 11% after issuing a weaker-than-expected outlook, citing the impact of rising memory chip prices on its margins. This sparked broader concerns about profitability within the technology sector.

By late morning trading, the S&P 500 had fallen 1%, while the Nasdaq 100 dropped 1.5%. All of the largest technology companies – often referred to as the “Magnificent 7” – were trading lower, and an exchange-traded fund tracking the software industry saw a decline of 3.5%.

The market’s reaction reflects increasing investor caution, according to Charlie Anderson of UBS Wealth Management. “Stocks are a little fatigued after a very strong start to 2026,” Anderson said. “Some of the biggest tech names in the market are being hit after reporting earnings, demonstrating that investor expectations have risen.”

Adding to the market’s unease, economic data released on Thursday offered little reassurance. Weekly jobless claims edged slightly lower, but existing home sales for January experienced their largest drop in four years, despite lower interest rates. This suggests continued strain on the housing market and reinforces concerns about a potential cooling of economic momentum.

Investors are now keenly focused on upcoming inflation data, which will likely influence the Federal Reserve’s future monetary policy decisions. While most traders still anticipate the Fed will hold steady at its next two meetings, the likelihood of interest rate cuts by June has increased, driven in part by the weaker retail sales data reported earlier in the week.

The consumer data, which showed virtually unchanged retail sales in December, signaled a slowdown in spending at the end of the holiday season. This data, combined with recent signs of softening in the labor market, has fueled speculation that the Fed may begin easing monetary policy sooner than previously expected.

Anna Wong of Bloomberg Economics offered a measured assessment of the current economic landscape. “Our conclusion is that the economy is not experiencing either widespread disinflation or a resurgence of inflation,” she stated. This suggests a delicate balancing act for the Fed as it navigates the competing risks of slowing economic growth and persistent inflationary pressures.

Beyond the technology sector, financial stocks also contributed to the market’s decline. Wells Fargo, Bank of America, and Citigroup all experienced losses following their respective earnings reports. While Bank of America reported stronger-than-expected profits, concerns about future expenses weighed on the stock. Citigroup, undergoing a restructuring under Chair and CEO Jane Fraser, also saw its shares fall.

The broader market weakness also extended to smaller-cap stocks, with the Russell 2000 index falling 1.8%. The S&P 500 Equal Weight Index, which gives equal weighting to all stocks in the index, also declined, indicating that the selling pressure was not limited to large-cap companies.

Biogen also contributed to the negative sentiment, sinking 5% after the biotechnology company warned of a hit to its fourth-quarter profits due to increased research and development expenses. This highlights the risks associated with investing in the pharmaceutical sector, where significant investments in innovation are often required.

The current market environment underscores the increasing sensitivity to corporate earnings and economic data. Investors are demanding strong growth and profitability from companies to justify high valuations, and any disappointment can trigger sharp selloffs. The coming days will be crucial as investors await further economic data, including the January jobs report and the latest Consumer Price Index reading, to gain a clearer picture of the economic outlook.

The volatility also comes after a period of strong gains for U.S. Equities, raising questions about whether the market may be due for a more significant correction. While the long-term outlook remains uncertain, investors are likely to remain cautious in the near term, particularly given the ongoing economic and geopolitical risks.

You may also like

Leave a Comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.